Search

Search Constraints

You searched for: Author/Creator Powell, Nick

Search Results

11. COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study. (April 2022)

13. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease. Issue 4 (24th February 2015)

14. Faecal calprotectin is a surrogate marker of biliary inflammation in primary sclerosing cholangitis associated inflammatory bowel disease. Issue 6 (18th March 2022)

15. Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma. Issue 4 (8th July 2020)

16. Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centres. Issue 3 (11th October 2017)

17. Human retinoic acid–regulated CD161+ regulatory T cells support wound repair in intestinal mucosa. (December 2018)

18. Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease: 775. (October 2019)

20. Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Issue 10 (26th April 2021)